A detailed history of Laurion Capital Management LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 1,481,006 shares of APLT stock, worth $6.34 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,481,006
Previous 431,006 243.62%
Holding current value
$6.34 Million
Previous $1.44 Million 597.85%
% of portfolio
0.09%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $2.36 Million - $7.77 Million
1,050,000 Added 243.62%
1,481,006 $10.1 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $156,595 - $285,105
85,106 Added 24.6%
431,006 $1.44 Million
Q2 2022

Aug 15, 2022

BUY
$0.76 - $2.64 $262,884 - $913,176
345,900 New
345,900 $328,000
Q2 2020

Aug 14, 2020

SELL
$29.41 - $51.23 $294,100 - $512,299
-10,000 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$19.54 - $55.47 $195,400 - $554,700
10,000 New
10,000 $327,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $206M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.